P2RX7 and epilepsy: While increased P2X7 protein levels during epilepsy have been widely reported (Engel et al., 2016), until recently, no evidence existed for an impact of P2X7 antagonism on the epileptic phenotype at all and, therefore, whether P2X7 blockade represents a possible new treatment strategy for epilepsy.